UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Lmcg Investments LLC

Lmcg Investments LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,952 shares of the healthcare conglomerate’s stock after buying an additional 1,629 shares during the quarter. UnitedHealth Group makes up approximately 1.2% of Lmcg Investments LLC’s investment portfolio, making the stock its 18th largest position. Lmcg Investments LLC’s holdings in UnitedHealth Group were worth $19,851,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD grew its stake in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after buying an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp grew its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after buying an additional 35,533 shares during the last quarter. International Assets Investment Management LLC grew its stake in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH traded up $3.06 during midday trading on Friday, reaching $567.56. 2,548,368 shares of the company’s stock were exchanged, compared to its average volume of 3,259,068. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The business has a 50-day simple moving average of $581.96 and a two-hundred day simple moving average of $541.50. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $524.10 billion, a price-to-earnings ratio of 36.97, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the company posted $6.56 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on UNH shares. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Truist Financial reissued a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, Wells Fargo & Company increased their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.